Friday, July 10, 2026

pharma · Kidney Dysfunction · Obesity

LianBio

LianBio clinical programs — 1 development programs from ClinicalTrials.gov with phase, modality, indication, and trial identifiers.

CN HQ
2019 Founded
47 Employees
NMPA registrant Type
Company details
Status
Public
HQ
CN
Founded
2019
Employees
47
Programs
28
Drugs
40
Patents
0
Intelligence · Clinical Programs

LianBio projects

1 ClinicalTrials.gov programs sponsored by LianBio.

LianBio has 1 clinical development programs indexed from ClinicalTrials.gov, including phase, modality, indication text, and linked NCT identifiers.

Clinical programs

  1. Bupivacaine Liposome Injection

    Jian Li

    Local Analgesia Via Infiltration

    approved small molecule active

    1 trial

Frequently asked questions

How many clinical projects does LianBio have?

1 published programs are linked to this sponsor in our ClinicalTrials.gov index.

Is this the complete company pipeline?

This directory lists published programs for the sponsor in our database. Partnered or out-licensed assets may appear under multiple companies.